Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Qmenta received $3 million in Seed capital in 2017. QMENTA has been growing since 2013 in EU & US, now supporting many multi-center studies and a number of clinical trials. The company was named “Best New Radiology Vendor” in 2017 by Aunt Minnie and was a European Winner for Accenture’s Healthtech Innovation Challenge and won the Sanofi Tech Lab challenge.
High for how long a period. I am talking about a year or so for this to reach 20 mill and maybe two years or more To get to 40 mill. I am not talking months here. I a looking way ahead
Thats way too high, first we need FDA approval and some more sales. And a trajectory, I think 4p for first target is fine for me personally.
Risiculous in what way - too high ??
Artificial intelligence to play major role in healthcare - Reuters
Aug. 31, 2018 1:05 PM ET|By: Douglas W. House, SA News Editor
Reuters reports that artificial intelligence (AI) will play a key role in the advancement of diagnoses and treatments across the healthcare spectrum.
Siemens Heathineers (OTCPK:SIEGY)(OTCPK:SMAWF) has leveraged AI to develop a digital twin heart that mimics the electrical and physical properties of real cardiac cells enabling surgeons to run simulations before surgery, to see if a pacemaker is appropriate for a particular patient, for example.
Philips sells AI-enabled heart models that convert two-dimensional ultrasound images into data that helps physicians diagnose problems or automatically analyze scans to help surgeons plan operations.
A shortage of doctors in China is stoking demand for AI tools to analyze medical images. Alibaba is one of the early leaders, using its cloud and data systems to develop AI solutions to analyze CT and MRI images.
Google has developed a portfolio of AI tools, including algorithms to analyze medical images to diagnose eye disease and to sort through medical records to predict patient outcomes.
According to Frost & Sullivan, the global market for AI tools is expected to jump to $6.7B in three years. The global market for imaging analytics software is forecasted to be $4.3B by 2025 according to Statista.
I bought a few more today on the dip. the only dips that worry me are the ones left over after a nacho fest then they have fungi in them cuz you aint thrown the dip box out on time. I think the market cap you have quoted is ridiculous by the way.
I agree too draft but these dips are quite worrying. I hope my other shares come good and I can then take money from there and add here. This is a serious long term for me where the company does hit a good 40 mill mcap which with its projects, innovations and sales is doable. Just requires time. Patience
w are clearly going to capture this space. David has a 30-year history of successfully building life sciences businesses in Europe and the United States, including Biocompatibles plc where he initiated the ophthalmology and cardiology businesses in a period that saw their sales grow from zero to over £40m pa, business development for Carl Zeiss in which he reinvigorated their mature ophthalmology capital equipment business to grow more than 15% pa resulting in sales in excess of £150m. In addition, the foundation of California based Tenaxis Medical, where having raised $22m from investors David led the company through product development, built a strong operating team, achieved regulatory approvals and secured the company's first sales. Tenaxis Medical was sold for $178m in 2014. Trevor Brown, CEO of Flying Brands, commented: "I am delighted to welcome David to Flying Brands. I believe that the Company will benefit greatly from the breadth of his experience, not only from his proven ability to actualize strategic vision into strongly growing revenue, but also from applying his deep knowledge of the US medical market to our growing Artificial Intelligence product portfolio."
Imaging Biometrics and QMENTA are joining their forces via QMENTA SDK to accelerate neuroscience research and increase accuracy in diagnostics support. Imaging Biometrics will integrate all IB modules; IB Neuro, IB Delta T1 Maps, IB Diffusion, and IB DCE on the cloud-based QMENTA platform that provides advanced data analysis and management for neuro experts. The integration of IB’s FDA cleared software on the QMENTA platform is carried out through its Software Development Kit (SDK).
but now LOOK WHERE QMENTA WENT TO!? SANOFI!!!!!!
In only a couple of years, VivaTech has become one of the most innovative events for startups. The third edition will take place in Paris from May 24th – 26th and will once again gather leaders from different fields all bonded by the development of new technologies in their sector.Sanofi – one of the biggest pharmaceutical companies in the world – will set up a “Tech for health” lab and has invited QMENTA – among other disruptive digital health startups – to showcase their amazing innovations in the presence of key opinion leaders and investors from all around the world.We are thrilled to exhibit at VivaTech! We are very honored to have been chosen by Sanofi and as this will be a great opportunity for us to present our platform and demonstrate how our technologies can impact drug discoveries in many ways.We will be looking forward to meeting Sanofi executives who will be guiding us and giving invaluable advice during these 3 days. We hope that this will flourish into a collaboration with Sanofi, we are looking forward to joining everyone at VivaTech this year.
Impossible, Unless they post. Wait for RNs
Can someone please answer my question about how u know a specific person has bought and sold at a specific price ?
Awaiting the FDA approval for the Kidney stone checking software, then we can begin marketing to the US. Suggest people watch the Nick Stevens video interviews, all very good.
Also dont forget the Neuro software is already being used by Harvard, Stanford, Mayo clinic and a phase 2 cancer trial
so FBDU being used at Mayo clinc, Stanford and a phase 2 cancer trial. I really think the revenue here will surpirse and the bulk of it coming from Imaging biometrics intitially
https://uk.webfg.com/news/news-and-announcements/flying-brands-ib-joins-multi-centre-cancer-trial--3400138.html
i think the revenue figure will surprise. IB NEURO appears to be certainly accelerating.
Let’s see if Zak is right. I just think we need to get that fda first. It sets everything up really
https://healthitanalytics.com/news/how-artificial-intelligence-is-changing-radiology-pathology
as per Zaks chart. surely we should go higher on FDA approval.
Looks like a 1,000,000 rollover
http://www.proactiveinvestors.co.uk/companies/stocktube/9932/stonechecker-still-on-track-for-fda-clearance-and-commercial-roll-out-of-software-9932.html
StoneChecker still on track for FDA clearance and commercial roll out of software
14:24 23 Jul 2018
Nick Stevens, chief executive of StoneChecker, which is part of the Flying Brands group (LON:FDBU) tells Proactive's Andrew Scott that despite a small delay in the US FDA clearance process, they're still looking at a commercial roll out in Q4 this year.
Once approved, the group aims to launch the software in the US, India and China by the end of the year while commercial sales in the UK are expected to begin in the fourth quarter.
StoneChecker received European CE clearance last December.
I know dude - I topped up at about 2.1 p. I neever thought it would go lower than that
youve had about 10 chances to top up. anyway looks like the distressed seller is out, delayed sells now showing
Damn u
Ive had about 3 top ups
Great. Now this is going to climb when I never got an opportunity to top up
I missed out big time on a top up opportunity. It was taken down for no reason but I have no cash anymore. Just need to see where we go with what I have. Did anybody else top up ?